Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 10:47AM
|
Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 04:07PM
|
Re: No mention of efficacy again...
|
4
|
Resverlogix Corp.
|
Mar 30, 2019 05:31AM
|
Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 03:21PM
|
Re: No mention of efficacy again...
|
3
|
Resverlogix Corp.
|
Mar 27, 2019 04:16PM
|
Re: No ESC 2019 Late Breaker
|
1
|
Resverlogix Corp.
|
Jul 02, 2019 08:33AM
|
Re: No ESC 2019 Late Breaker
|
1
|
Resverlogix Corp.
|
Jul 02, 2019 10:26AM
|
Re: No data, No communication,,no interest!!
|
4
|
Zenith Epigenetics
|
Dec 29, 2023 10:04AM
|
Re: NKF meeting
|
3
|
Resverlogix Corp.
|
Feb 26, 2020 05:14PM
|
Re: Nine Months, 2021- Financials and MD&A on SEDAR
|
2
|
Resverlogix Corp.
|
Nov 14, 2021 06:53AM
|
Re: NIH's Long-COVID studies
|
1
|
Resverlogix Corp.
|
Jul 09, 2022 07:36AM
|
Re: NIH's Long-COVID studies
|
1
|
Resverlogix Corp.
|
Jul 09, 2022 04:12PM
|
Re: Nightmare scenario......for short players.
|
1
|
Resverlogix Corp.
|
Apr 18, 2019 12:56PM
|
Re: Nightmare scenario......for short players.
|
3
|
Resverlogix Corp.
|
Apr 18, 2019 02:11PM
|
Re: Nightmare scenario......for short players.
|
2
|
Resverlogix Corp.
|
Apr 18, 2019 02:33PM
|
Re: Nice run for Hepa over the holidays
|
3
|
Resverlogix Corp.
|
Jan 06, 2020 02:10PM
|
Re: Nice problem to have....
|
2
|
Resverlogix Corp.
|
Mar 02, 2020 11:25AM
|
Re: Nice problem to have....
|
3
|
Resverlogix Corp.
|
Mar 02, 2020 11:41AM
|
Re: nice drop!
|
|
Resverlogix Corp.
|
Feb 24, 2020 05:20PM
|
Re: nice drop!
|
1
|
Resverlogix Corp.
|
Feb 24, 2020 06:30PM
|